首頁 > 市場調查報告書 > 製藥

e保健處方藥

市場調查報告書

商品編碼

1866550

全球藥物治療管理市場－2025-2030年預測

Global Medication Management Market - Forecasts from 2025 to 2030

出版日期: 2025年11月04日 | 出版商:

Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

全球藥物治療管理市場預計將從 2025 年的 37.95 億美元成長到 2030 年的 68.51 億美元，複合年成長率為 12.54%。

藥物治療管理市場是醫療保健領域的關鍵板塊，專注於以患者為中心的系統，旨在最佳化安全、有效和適當的藥物治療。這些系統簡化了臨床操作，確保藥物的準確給藥和患者依從性。日益複雜的治療方法、慢性病盛行率的上升以及技術的進步正在推動市場發展，但高昂的實施成本仍然是一大挑戰。

本報告檢驗了當前藥物治療管理市場的需求、供應和銷售趨勢，以及影響該市場發展的最新動態。報告全面分析了關鍵促進因素、阻礙因素和機遇，並詳細說明了區域產業趨勢、政策和法規，以幫助相關人員深入了解法規結構和市場動態。

我們的競爭情報是基於廣泛的二手研究，包括產業協會調查、分析師報告、投資者報告、新聞稿和學術期刊，旨在識別主要企業及其收入貢獻。市場規模採用自下而上和自上而下的方法計算，並透過來自全球藥物治療管理價值鏈相關人員的第一手資訊檢驗。我們全面的市場分析整合了各種資訊來源和專有資料集，並運用資料三角測量技術，提供準確的市場區隔和預測。我們透過分析敘述、圖表和圖形呈現洞察，以幫助讀者有效率地理解。 2024年全球市場規模約26億美元，預計2030年將達到58億美元，複合年成長率（CAGR）為14.3%。主要企業包括Genoa Healthcare、Becton, Dickinson & Company、SinfoniaRx（Tabula Rasa Healthcare旗下公司）、CSAM Health AS、 Honeywell International、GE Healthcare、Talyst LLC、Cerner Corporation、OptumRx和McKesson Corporation。

主要亮點

複雜治療方法：先進治療方法的出現推動了對高效能藥物治療管理系統的需求。
慢性疾病：慢性疾病的日益普及（到 2024 年將影響全球 60% 的成年人）正在推動市場成長。
技術進步：遠距藥物治療管理和玫瑰花結系統等創新正在創造成長機會。
成本障礙：高昂的安裝和維修成本阻礙了其普及，尤其是在小規模的醫療機構。

成長要素

慢性病發病率的上升（預計2024年全球整體成長5%）對藥物治療管理提出了更高的要求，以確保病患監測與營運效率。醫療保健資訊科技的日益普及，尤其是在北美地區（預計2024年數位醫療投資將成長10%），正在推動市場擴張。

阻礙因素

綜合醫療保健系統的實施涉及高昂的初始成本（平均50萬美元）以及持續的維護成本，這限制了其在小規模醫療機構中的應用。與現有醫療保健系統的整合挑戰增加了實施的複雜性。新興市場技術專長的缺乏也阻礙了其進一步的擴充性。

細分市場分析

按軟體類型分類：庫存管理系統由於其在最大限度減少資源浪費方面主導的作用，預計到2024年將佔據35%的市場佔有率。臨床決策支援系統由於其在提高患者安全方面發揮的作用，正在快速成長。

按交付方式分類：雲端基礎的解決方案處於主導，提供擴充性和遠端訪問，而本地部署系統在對安全性要求較高的環境中繼續蓬勃發展。

按最終用戶分類：醫院佔比最大，但隨著遠端醫療的發展趨勢，藥房和居家醫療領域的採用率正在不斷提高。

區域分析

到2024年，北美將佔據42%的市場佔有率，這主要得益於美國醫療保健產業的高IT應用率以及150億美元的數位醫療投資。亞太地區將以16%的複合年成長率成長，主要受中國和印度慢性病患病率上升以及醫療保健現代化進程的推動。歐洲則憑藉其支持性的數位醫療政策取得了進展。

本報告為業內人士提供關於市場趨勢、監管環境和競爭動態的關鍵洞察。報告重點闡述了先進治療方法和數位醫療整合領域的機遇，同時也探討了成本和整合的挑戰。嚴謹的調查方法，結合一手和二手數據，確保了預測的可靠性，使相關人員能夠理解複雜的市場格局，並優先考慮在這一重要醫療保健領域的投資。

本報告的主要優勢：

深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略打入市場的潛力。
市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

歷史資料（2022-2024 年）和預測資料（2025-2030 年）
成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
競爭對手定位、策略和市場佔有率分析
按業務板塊和地區（國家）分類的收入成長和預測分析
公司概況（策略、產品、財務資訊、關鍵趨勢等）

介紹
北美洲
- 依軟體類型
- 透過供應方法
- 最終用戶
- 按國家/地區
  - 美國
  - 加拿大
  - 墨西哥
南美洲
- 依軟體類型
- 透過供應方法
- 最終用戶
- 按國家/地區
  - 巴西
  - 阿根廷
  - 其他
歐洲
- 依軟體類型
- 透過供應方法
- 最終用戶
- 按國家/地區
  - 英國
  - 德國
  - 法國
  - 義大利
  - 其他
中東和非洲
- 依軟體類型
- 透過供應方法
- 最終用戶
- 按國家/地區
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 其他
亞太地區
- 依軟體類型
- 透過供應方法
- 最終用戶
- 按國家/地區
  - 日本
  - 中國
  - 印度
  - 韓國
  - 台灣
  - 其他

第9章：競爭格局與分析

主要企業和策略分析
市佔率分析
企業合併、協議、商業合作
競爭對手儀錶板

第10章：公司簡介

Optum United Health
Becton, Dickinson and Company
Omda AS
Honeywell International Inc.
GE Healthcare Technologies, Inc.
Talyst, LLC（Swisslog Healthcare）
Oracle Health
McKesson Corporation
Omnicell, Inc.
Cardinal Health Inc.
Baxter International, Inc.

第12章分析方法

簡介目錄

Product Code: KSI061612027

The Global Medication Management Market is set to grow from USD 3.795 billion in 2025 to USD 6.851 billion by 2030, driven by a 12.54% CAGR.

The medication management market is a critical segment of healthcare, focusing on patient-centered systems to optimize safe, effective, and appropriate drug therapy. These systems streamline clinical operations, ensuring accurate medication administration and adherence. The market is driven by the rise of complex therapies, increasing chronic disease prevalence, and technological advancements, though high implementation costs pose challenges.

This research examines current trends in demand, supply, and sales, alongside recent developments shaping the medication management market. It provides a comprehensive analysis of key drivers, restraints, and opportunities, detailing industry trends, policies, and regulations across geographical regions to equip stakeholders with insights into the regulatory framework and market dynamics.

Competitive intelligence identifies major industry players and their revenue contributions, derived from extensive secondary research, including industry association studies, analyst reports, investor presentations, press releases, and journals. Market size for the overall sector and key segments was determined using bottom-up and top-down methodologies, validated with primary inputs from stakeholders in the global medication management value chain. Comprehensive market engineering integrated data from diverse sources and proprietary datasets, employing data triangulation for accurate market breakdown and forecasting. Insights are presented through analytical narratives, charts, and graphics for efficient comprehension. The global market was valued at approximately USD 2.6 billion in 2024 and is projected to reach USD 5.8 billion by 2030, growing at a CAGR of 14.3%. Key players profiled include Genoa Healthcare, Becton, Dickinson and Company, Sinfonia Rx (A Tabula Rasa Healthcare Company), CSAM Health AS, Honeywell International Inc., GE Healthcare, Talyst, LLC, Cerner Corporation, OptumRx, and McKesson Corporation.

Key Highlights

Complex Therapies: Emergence of advanced therapies drives demand for efficient medication management systems.
Chronic Diseases: Rising prevalence of chronic conditions, affecting 60% of adults globally in 2024, fuels market growth.
Technological Advancements: Innovations like remote medication management and rosette systems create growth opportunities.
Cost Barriers: High implementation and maintenance costs hinder adoption, particularly for smaller healthcare facilities.

Growth Drivers

The rise in chronic diseases, with global cases increasing by 5% in 2024, necessitates robust medication management to ensure adherence and safety. An aging population, projected to reach 1.5 billion by 2050, increases demand for systems to manage complex medication regimens. Technological advancements, such as remote medication management systems introduced by McKesson in 2024, enhance patient monitoring and operational efficiency. Growing healthcare IT adoption, particularly in North America, with a 10% increase in digital health investments in 2024, supports market expansion.

Restraints

High implementation costs, averaging USD 500,000 for comprehensive systems, and ongoing maintenance expenses limit adoption in smaller healthcare settings. Integration challenges with legacy healthcare systems increase deployment complexity. Limited technical expertise in emerging markets further restricts scalability.

Segmentation Analysis

By Software Type: Inventory management systems dominate with a 35% share in 2024, driven by their role in minimizing resource wastage. Clinical decision support systems grow rapidly for enhanced patient safety.

By Delivery Mode: Cloud-based solutions lead, offering scalability and remote access, while on-premise systems persist in secure environments.

By End-User: Hospitals command the largest share, with pharmacies and homecare settings expanding due to telehealth trends.

Regional Analysis

North America holds a 42% market share in 2024, driven by high IT adoption in the U.S. healthcare sector and investments of USD 15 billion in digital health. Asia Pacific grows at a 16% CAGR, fueled by rising chronic disease prevalence and healthcare modernization in China and India. Europe advances through supportive digital health policies.

This report equips industry experts with critical insights into market trends, regulatory landscapes, and competitive dynamics. It highlights opportunities in advanced therapies and digital health integration while addressing cost and integration challenges. The rigorous methodology, blending primary and secondary data, ensures reliable projections, enabling stakeholders to navigate complexities and prioritize investments in this essential healthcare sector.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Software Type

Computerized Physician Order Entry (CPOE)
Clinical Decision Support Systems (CDSS)
Electronic Medication Administration Records (eMAR)
Inventory & Dispensing Management

By Delivery Mode

On-Premise
Cloud-Based

By End-User

Hospitals & Clinics
Pharmacies
Ambulatory Surgical Centers
Long-Term Care Facilities

By Geography

North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Italy
Others
Middle East & Africa
Saudi Arabia
UAE
Others
Asia Pacific
Japan
China
India
South Korea
Taiwan
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL MEDICATION MANAGEMENT MARKET BY SOFTWARE TYPE

5.1. Introduction
5.2. Computerized Physician Order Entry (CPOE)
5.3. Clinical Decision Support Systems (CDSS)
5.4. Electronic Medication Administration Records (eMAR)
5.5. Inventory & Dispensing Management

6. GLOBAL MEDICATION MANAGEMENT MARKET BY DELIVERY MODE

6.1. Introduction
6.2. On-Premise
6.3. Cloud-Based

7. GLOBAL MEDICATION MANAGEMENT MARKET BY END-USER

7.1. Introduction
7.2. Hospitals & Clinics
7.3. Pharmacies
7.4. Ambulatory Surgical Centers
7.5. Long-Term Care Facilities

8. GLOBAL MEDICATION MANAGEMENT MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. By Software Type
- 8.2.2. By Delivery Mode
- 8.2.3. By End-User
- 8.2.4. By Country
  - 8.2.4.1. United States
  - 8.2.4.2. Canada
  - 8.2.4.3. Mexico
8.3. South America
- 8.3.1. By Software Type
- 8.3.2. By Delivery Mode
- 8.3.3. By End-User
- 8.3.4. By Country
  - 8.3.4.1. Brazil
  - 8.3.4.2. Argentina
  - 8.3.4.3. Others
8.4. Europe
- 8.4.1. By Software Type
- 8.4.2. By Delivery Mode
- 8.4.3. By End-User
- 8.4.4. By Country
  - 8.4.4.1. United Kingdom
  - 8.4.4.2. Germany
  - 8.4.4.3. France
  - 8.4.4.4. Italy
  - 8.4.4.5. Others
8.5. Middle East & Africa
- 8.5.1. By Software Type
- 8.5.2. By Delivery Mode
- 8.5.3. By End-User
- 8.5.4. By Country
  - 8.5.4.1. Saudi Arabia
  - 8.5.4.2. UAE
  - 8.5.4.3. Others
8.6. Asia Pacific
- 8.6.1. By Software Type
- 8.6.2. By Delivery Mode
- 8.6.3. By End-User
- 8.6.4. By Country
  - 8.6.4.1. Japan
  - 8.6.4.2. China
  - 8.6.4.3. India
  - 8.6.4.4. South Korea
  - 8.6.4.5. Taiwan
  - 8.6.4.6. Others